Streetbeat News

Stock Prices

ETHUSD

Crypto billionaire Justin Sun has reportedly purchased $49 million worth of Ethereum over the past three days, as the cryptocurrency's price dipped. This move is seen as a bullish signal ahead of the anticipated launch of spot Ethereum ETFs and follows the closure of the SEC's investigation into Ethereum's security status.

Portfolio Pulse from Aniket Verma

June 24, 2024 | 7:17 am

GUTS

Fractyl Health, Inc. (NASDAQ:GUTS) presented new preclinical data on its Rejuva pancreatic gene therapy program for obesity and type 2 diabetes at the American Diabetes Association's 84th Scientific Sessions. The study showed promising results in maintaining body composition and glycemia in a mouse model after semaglutide withdrawal.

Portfolio Pulse from Benzinga Newsdesk

June 24, 2024 | 7:12 am

TAK

Takeda (TAK) presented positive Phase 2b trial results for mezagitamab (TAK-079) in treating primary immune thrombocytopenia (ITP). The study showed significant improvements in platelet response and reduced bleeding events. Takeda plans to initiate a global Phase 3 trial in FY2024.

Portfolio Pulse from Benzinga Newsdesk

June 24, 2024 | 7:09 am

NRBO

NeuroBo Pharmaceuticals (NASDAQ:NRBO) announced pre-clinical data showing that its novel drug DA-1726 is superior in weight loss, lean body mass retention, and lipid-lowering effects compared to survodutide. The data will be presented at the ADA 2024 Scientific Sessions.

Portfolio Pulse from Benzinga Newsdesk

June 24, 2024 | 7:06 am

MNKD

MannKind Corporation (NASDAQ:MNKD) announced positive 17-week results from the INHALE-3 study, a Phase 4 U.S. clinical trial evaluating Afrezza® (inhaled insulin) vs. usual care. The study met its primary efficacy endpoint, showing non-inferior changes in HbA1c and better glycemic target achievement in the inhaled insulin group.

Portfolio Pulse from Benzinga Newsdesk

June 24, 2024 | 7:04 am

TERN

Terns Pharmaceuticals (NASDAQ:TERN) announced preclinical data for its obesity treatment, TERN-501, which will be presented at the ADA 2024 Scientific Sessions. The data highlights the combination of TERN-501, a THR-β receptor agonist, with a GLP-1 receptor agonist.

Portfolio Pulse from Benzinga Newsdesk

June 24, 2024 | 6:59 am

MDT

Medtronic plc (NYSE:MDT) presented new data at the American Diabetes Association's 84th Scientific Sessions showcasing the benefits of its MiniMed™ 780G system in addressing hyperglycemia and reducing nighttime burden for diabetes patients. The data highlights significant improvements in managing high blood sugar levels and reducing sleep disruptions compared to the previous MiniMed™ 770G system.

Portfolio Pulse from Benzinga Newsdesk

June 24, 2024 | 6:57 am

PODD

Insulet Corporation (NASDAQ:PODD) announced positive results from its Omnipod 5 Automated Insulin Delivery System pivotal trial for type 2 diabetes at the ADA 84th Scientific Sessions. The trial showed significant glycemic improvements, reduced HbA1c, and improved time in range without increasing hypoglycemia.

Portfolio Pulse from Benzinga Newsdesk

June 24, 2024 | 6:56 am

DOGEUSD

PEPEUSD

RUNESUSD

Crypto analyst Michaël van de Poppe criticizes meme coins but highlights Dogecoin (DOGE), Bitcoin-based DOG (RUNES), and Pepe (PEPE) as having potential for high returns. Despite a current downturn in these coins, he forecasts an altcoin market rebound in the coming weeks.

Portfolio Pulse from Aniket Verma

June 24, 2024 | 5:25 am

TSLA

Gary Black, Managing Partner at Future Fund, criticized Delaware judges for overstepping their roles in a Tesla Inc. (NASDAQ:TSLA) case involving Elon Musk's $56 billion pay package. The Delaware General Assembly passed Senate Bill 313 to restrain judicial activism, reflecting ongoing tensions between the judiciary and legislative bodies.

Portfolio Pulse from Benzinga Neuro

June 24, 2024 | 4:41 am